Brussels, Brussels Region, Belgium
Phase IV epidemiology and clinical development studies on RTS,S/AS01 vaccine against Malaria. Malaria prevalence and control interventions evolution over time in African pediatric population study (PASS). Plasmodium DNA genotyping & strain replacement monitoring study (PASS). Clinical and scientific oversight of collaborating African investigational sites. Collaboration with institutional external partners (WHO, PATH, Harvard University, Broad Institute). Managing Regulatory Authorities (EMA/PRAC) interactions.
Infectious diseases national surveillance: vaccine-preventable diseases (Measles, Meningitis), healthcare-associated infections, antibiotics resistance, imported diseases (Dengue, Malaria...). National prevalence study of healthcare-associated infections and antimicrobial resistance.
Monitoring & Evaluation of 2 nutrition programs for MSF in Burkina Faso. Nutritional program coverage study using clustering method (CSAS). Hiring, training and supervision of a 38 investigators and data managers team.